Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study.
about
Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivorsNeurocognitive sequelae of childhood cancers and their treatmentExecutive function, coping, and behavior in survivors of childhood acute lymphocytic leukemiaCentral nervous system prophylaxis in haematological malignancies.Immediate treatment effects of high-dose methotrexate and cranial irradiation on neuropsychological functions of children treated for acute lymphoblastic leukemia at a regional cancer centerFolate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy.Neurocognitive outcome in survivors of childhood acute lymphoblastic leukemia: experience at a tertiary care hospital in Korea.Feasibility of neuropsychological assessment in leukaemia patients shortly after diagnosis: directions for future prospective research.F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia.Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia.Mathematics intervention for prevention of neurocognitive deficits in childhood leukemiaAdvancing biobehavioral research in childhood cancer.Neurodevelopmental functioning in very young children undergoing treatment for non-CNS cancersOxidative stress and neurobehavioral problems in pediatric acute lymphoblastic leukemia patients undergoing chemotherapy.Neurocognitive Predictors of Academic Outcomes Among Childhood Leukemia SurvivorsSmaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia.The Association Between Motor Skills and Academic Achievement Among Pediatric Survivors of Acute Lymphoblastic Leukemia.Voxel-based analysis of T2 hyperintensities in white matter during treatment of childhood leukemia.Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia.Disruption of learning processes by chemotherapeutic agents in childhood survivors of acute lymphoblastic leukemia and preclinical modelsLate effects of childhood leukemia therapy.Motor functioning during and following treatment with chemotherapy for pediatric acute lymphoblastic leukemia.Psychological, demographic, illness and treatment risk factors for emotional distress amongst paediatric oncology patients prior to reaching 5-year survivorship status.Reduced frontal white matter volume in long-term childhood leukemia survivors: a voxel-based morphometry study.Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol.Methotrexate-induced alterations in beta-oxidation correlate with cognitive abilities in children with acute lymphoblastic leukemia.Everyday executive function in standard-risk acute lymphoblastic leukemia survivors.Working memory performance in typically developing children and adolescents: behavioral evidence of protracted frontal lobe development.Gross and fine motor skills in children treated for acute lymphoblastic leukaemia.Predictive factors of internalized and externalized behavioral problems in children treated for acute lymphoblastic leukemia.Neurocognitive impairment in children treated for cancer: how do we measure cognitive outcomes?Adult survivors of childhood acute lymphoblastic leukaemia with GH deficiency have normal self-rated quality of life but impaired neuropsychological performance 20 years after cranial irradiation.Maternal smoking habits and cognitive development of children at age 4 years in a population-based birth cohort
P2860
Q26825655-08770973-E748-460A-BEBD-08DE385EBBA0Q28240816-A499BF1A-1106-4632-8392-77174C125F0EQ30436612-84B6E2E8-E4E1-4FD9-8822-23563B7B17A3Q34660525-FE58A85D-FDC7-47F2-BE69-031286AAE17CQ34686266-5095A94D-C08F-49E7-A7AF-0212891168DDQ35098712-5170C04E-578E-4E62-86DF-00DDBF7BAF78Q35198585-8388876B-64A0-4616-A455-116CF0B31CB8Q35282807-BEEB9106-69EC-4F45-B925-F22FB33C9CB2Q35557328-464E5BEA-7E4B-4A4C-B066-508144094F9BQ35580998-A929880E-0ABD-43E8-9B5A-CDA73EA54A2EQ35635557-7E27C4F8-30B3-4A77-8C7A-FC0D60A3260BQ35856579-A94EE642-F0D0-469B-91AF-74A5A44D85DCQ36054142-92B6C26E-1171-42C8-B5A8-060611B06C81Q36082861-569CC5B1-9F9F-4C0A-829F-9499F61A5989Q36445713-C0CB8866-AF79-4365-8E49-C2E6EF47DDECQ36677462-283FB6FB-0E10-4700-B777-6C7A2B046178Q36855070-F6C1D897-D61F-4938-AF3A-ABA5DA851BE7Q37438016-32BEA8BE-5F00-4ECF-95EB-7846E6199460Q37592244-C19FBC63-5C37-4E4E-A239-344181428996Q37879488-02CE6CA0-5A23-4E4E-93A8-8139B48F09A0Q37892981-86905A93-8341-4369-941F-FE2421AE3120Q38101016-34BCB956-4B37-4EA9-8DC9-8A875C86B897Q39194470-F34D4296-3D14-418B-B2FC-3604BF90930BQ40135664-2849C62A-CA4A-44D2-B91F-A1844ACE5EECQ46407191-A93BEDB1-59C4-486B-907C-54C0E67FCD52Q46656584-97F69B7F-E87A-4DBE-9145-1BD223DE8C21Q47930076-CF105CEA-E4C3-4706-A34D-B343D500E0EFQ48270723-3B5F1C5A-F74C-4C23-BC94-2078749B2AF5Q50483055-6349FD40-8CC0-4AF3-9A00-DBC07B094261Q50971306-7E1E4BC5-BDA2-4A82-ADDD-CC0FF320161EQ51889623-C460F49F-C02C-40CA-B2F5-309A1300E83EQ53221810-7163831A-195F-4EDA-832B-61BFADDAB23BQ57708391-B2741224-3478-4F8C-B7B7-28B071010295
P2860
Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Chemotherapeutic CNS prophylax ...... leukemia: a prospective study.
@en
Chemotherapeutic CNS prophylax ...... leukemia: a prospective study.
@nl
type
label
Chemotherapeutic CNS prophylax ...... leukemia: a prospective study.
@en
Chemotherapeutic CNS prophylax ...... leukemia: a prospective study.
@nl
prefLabel
Chemotherapeutic CNS prophylax ...... leukemia: a prospective study.
@en
Chemotherapeutic CNS prophylax ...... leukemia: a prospective study.
@nl
P2093
P356
P1476
Chemotherapeutic CNS prophylax ...... leukemia: a prospective study.
@en
P2093
P356
10.1093/JPEPSY/26.1.1
P577
2001-01-01T00:00:00Z